The Boyden chamber assay showed that LIMK1/CDK5 significantly promoted the invasion of EAC, gastric cancer, and lung cancer cells in a phosphorylation‐dependent manner (Figure S9E,F, Supporting Information). This evidence concerns the gene CDK5 and lung carcinoma.